MicroPort Scientific : Dongguan Kewei Recognized as "Company with Patent Advantage" in ...

Dongguan, China - On September 30, Dongguan Kewei Medical Instrument Co., Ltd. ('Dongguan Kewei'), a wholly owned subsidiary of Shanghai MicroPort Medical (Group) Co., Ltd. ('MicroPort'), was recognized as one of the local companies with patent advantages in 2016 by Dongguan Science and Technology Bureau. Such honor represents recognition and support from the government, and will greatly elevate the brand value.

Since establishment, Dongguan Kewei has laid emphasis on in-house R&D and intellectual property protection. Several of its key products were counted as provincial-level key new products, new- and high-technology products, and Guangdong independent innovative products, and were granted provincial-level science and technology progress award. Up to date, it has 47 authorized patents, among which 9 are invention patents, 23 are utility model patents, and 15 are design patents.

According to 'the rules to support patent projects in Dongguan,' Dongguan government names several enterprises that stand out in the year for patent exploitation, application, protection and management, to support their development and encourage other enterprises to follow their steps. Recognized enterprises have to meet certain requirements including no less than 30 million yuan of sales revenue, no less than 30 patents, as well as the number and quality of patents leading in the industry and increasing yearly over the recent two years. This recognition of Donguan Kewei will further encourage the company to innovate and protect its intellectual properties to buoy the healthy development of the company.

About MicroPort

MicroPort Scientific Corporation (the 'Group') is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 15 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.

For more information, please refer to: www.microport.com

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words 'believe', 'intend', 'expect', anticipate', 'project', 'estimate', 'predict', 'is confident', 'has confidence' and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort's management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 2016 MicroPort Scientific Corporation